Filter
714
Filtered Results: 714
Text search:
pharmaceutical
quality
control
laboratories
Featured
Recommendations
77
New Publications
216
Language
Document type
No document type
360
Studies & Reports
135
Guidelines
114
Strategic & Response Plan
51
Manuals
37
Training Material
7
Situation Updates
6
Fact sheets
3
Resource Platforms
1
Countries / Regions
India
43
Kenya
33
Ethiopia
29
Nigeria
19
Western and Central Europe
17
South Africa
17
Ghana
15
Sierra Leone
15
Uganda
15
Global
14
Nepal
13
Bangladesh
13
Liberia
13
Malawi
12
Tanzania
12
Philippines
11
Eastern Europe
10
Rwanda
9
Africa
9
Cambodia
9
Zambia
9
Namibia
8
Ukraine
7
Senegal
6
Burkina Faso
6
Zimbabwe
6
Latin America and the Carribbean
6
South–East Asia Region
6
Myanmar / Burma
6
Syria
5
Eswatini/ Swaziland
5
Thailand
4
Lesotho
4
Benin
4
Haiti
4
Botswana
4
Indonesia
4
Cameroon
3
Congo, Democratic Republic of
3
West and Central Africa
3
East and Southern Africa
3
Vietnam
3
Pakistan
3
Albania
2
Laos
2
Guinea
2
USA
2
Asia
2
Venezuela
2
Western Pacific Region
2
Madagascar
2
North Macedonia
1
Tajikistan
1
Timor Leste/ East Timor
1
El Salvador
1
China
1
Iran
1
Fiji
1
Afghanistan
1
Peru
1
Mozambique
1
Jordan
1
Saudi Arabia
1
Eastern Europe and Central Asia
1
North America
1
Gabon
1
Turkmenistan
1
France
1
Maldives
1
Papua New Guinea
1
Moldova
1
Sudan
1
Yemen
1
Mali
1
Iraq
1
Somalia
1
Authors & Publishers
Publication Years
Category
Countries
340
Clinical Guidelines
36
Key Resources
35
Pharmacy & Technologies
22
Public Health
20
Women & Child Health
13
Capacity Building
3
Toolboxes
AMR
123
COVID-19
54
Pharmacy
54
TB
46
Rapid Response
36
NTDs
22
HIV
18
Mental Health
16
Malaria
13
Planetary Health
11
Conflict
10
Health Financing Toolbox
9
Caregiver
8
Polio
8
Ebola & Marburg
6
Global Health Education
6
Specific Hazards
5
Natural Hazards
4
NCDs
4
Refugee
3
Cholera
3
Zika
2
Bioethics - Medical, Ethical and Legal Perspectives
There’s evidence that implementing the four medical ethics principles may be challenging especially in low income country contexts with extreme resource scarcity and limited capacity to facilitate deliberations on the different ethical dilemmas....
Consultancy Report May 2022
The World Drug Report 2022 is aimed not only at fostering greater international cooperation to counter the impact of the world drug problem on health, governance and security, but also, with its special insights, at assisting Member States in anticipating and address-ing threats from drug markets an...
I examine the effectiveness of donors in targeting the highest burden of malaria in the Democratic Republic of Congo when health information structure is fragmented. I exploit local variations in the burden of malaria induced by mining activities as well as financial and epidemiological data from he...
Why bold action against inequalities is needed to en AIDS, stop COVID-19 and prepare for future pandemics
(Last Update: July 2022)
This curriculum can be used freely in order to stimulate means of ethical analysis, reflection and decision-making.
On 31st December 2019, the World Health Organization (WHO) China Country Office was informed of cases of pneumonia of unknown etiology (unknown cause) detected in Wuhan City, Hubei Province of China. On 7th January 2020, Chinese authorities identified a new strain of Coronavirus as the causative age...
WHO needs US$2.54 billion to provide life-saving assistance to millions of people around the world facing health emergencies. WHO’s Health Emergency Appeal is a consolidation of WHO’s priorities and financial requirements for 2023 to carry out health interventions in emergency and humanitarian r...
Strengthening health-system emergency preparedness.
The handbook on supply chain management for HIV/AIDS commodities was written to assist program managers to plan and implement day–to-day management of all drugs and medical supplies for an HIV/AIDS program. Many of the suggested techniques described in this handbook are helpfu...
A call for national and regional containment, recovery and prevention
Opiates, cocaine, cannabis
World Drug Report 2017
-3-
Accessed: 14.03.2019
This document lays out economic arguments for investing in the Access to COVID-19 Tools Accelerator (ACT-Accelerator). Framed within an overall context that recognizes the broader human health and societal impacts of the COVID-19 crisis, ACT-Accelerator's Economic Investment Case argues that investm...
